Ocugen (OCGN) Other Non-Current Assets (2014 - 2026)
Ocugen's (OCGN) quarterly Other Non-Current Assets came in at $318000.0 in Q1 2026, up 2.91% YoY from $309000.0 in Q1 2025, and up 0.63% on a QoQ basis from $316000.0 in Q4 2025.
Analysis
Ocugen (OCGN) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Other Non-Current Assets data on file, last reported at $318000.0 in Q1 2026.
- Quarterly Other Non-Current Assets rose 2.91% year-over-year to $318000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $318000.0 (up 2.91% YoY) and the FY2025 annual result came in at $316000.0, up 2.93% from the prior year.
- Other Non-Current Assets rose to $318000.0 in Q1 2026, from $316000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $5.0 million in Q2 2025 to a low of $151000.0 in Q1 2022.
- A 5-year average of $1.9 million and a median of $316000.0 in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 2791.39% — and 2024, when it sank 92.84%.
- Tracing OCGN's Other Non-Current Assets over 5 years: stood at $4.1 million in 2022, then climbed by 4.87% to $4.3 million in 2023, then slumped by 92.84% to $307000.0 in 2024, then gained by 2.93% to $316000.0 in 2025, then climbed by 0.63% to $318000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $318000.0 (Q1 2026), $316000.0 (Q4 2025), and $314000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | 3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.82 Mn |
| Mar 31, 2026 | 4.21 Mn |
| Dec 31, 2025 | 4.47 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Jun 30, 2025 | 312,000.00 |
| Mar 31, 2025 | 309,000.00 |
| Dec 31, 2024 | 3.90 Mn |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | 302,000.00 |
| Dec 31, 2023 | 4.29 Mn |
| Mar 31, 2023 | 3.95 Mn |
| Dec 31, 2022 | 4.09 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 4.37 Mn |
| Mar 31, 2022 | 1.63 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Sep 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 151,000.00 |
| Mar 31, 2021 | 151,000.00 |
| Dec 31, 2020 | 714,000.00 |